Questions
Tournaments
Services
News
Questions
Tournaments
Questions
Questions
More
Log in
Sign Up
Log in
Sign Up
38
11
forecasters
5
38 comments
11 forecasters
Respiratory Outlook 2023/24
3 more...
When will the RSV monoclonal antibody nirsevimab (Beyfortus) no longer be in shortage in the US?
Follow
share
embed
community
11 Oct 2024
result
01 Apr 2024 08:00 UTC
Resolved
01 Apr 2024 08:00 UTC
Forecast Timeline
1d
1w
2m
all
Forecast Timeline
1d
1w
2m
all
Comments (38)
Timeline
Key Factors (0)
Question Info
Similar Questions
No key factors yet
Add some that might influence this forecast.
2 comments
5 forecasters
Intranasal SARS-CoV-2 vaccine in US
Current estimate
14 Jan 2030
26 comments
41 forecasters
Average US Measles Cases 2025 through 2030?
Current estimate
>1000 cases
7 comments
1 forecaster
English Vanza Approval
Current estimate
16 Mar 2026
10 comments
57 forecasters
Development of Universal Flu Vaccine
Current estimate
09 Mar 2031
2 comments
25 forecasters
New Tuberculosis Vaccine before 2028
70%
chance
0 comments
17 forecasters
HSV-1 Vaccine Approved by FDA
Current estimate
Jul 2033
17 comments
18 forecasters
Date of M72 license from WHO-listed regulator?
Current estimate
Dec 2031
18 comments
19 forecasters
FDA approval date of microneedle vaccine?
Current estimate
Jun 2032